Cargando…
Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s disease
BACKGROUND: Previous studies have reported that gut microbiota, permeability, short-chain fatty acids (SCFAs), and inflammation are altered in Parkinson’s disease (PD), but how these factors are linked and how they contribute to disease processes and symptoms remains uncertain. This study sought to...
Autores principales: | Aho, Velma T. E., Houser, Madelyn C., Pereira, Pedro A. B., Chang, Jianjun, Rudi, Knut, Paulin, Lars, Hertzberg, Vicki, Auvinen, Petri, Tansey, Malú G., Scheperjans, Filip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869249/ https://www.ncbi.nlm.nih.gov/pubmed/33557896 http://dx.doi.org/10.1186/s13024-021-00427-6 |
Ejemplares similares
-
Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression
por: Aho, Velma T.E., et al.
Publicado: (2019) -
Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms
por: Xie, Aoji, et al.
Publicado: (2022) -
The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?
por: Houser, Madelyn C., et al.
Publicado: (2017) -
Multiomics implicate gut microbiota in altered lipid and energy metabolism in Parkinson’s disease
por: Pereira, Pedro A. B., et al.
Publicado: (2022) -
Gut microbiota composition is associated with narcolepsy type 1
por: Lecomte, Alexandre, et al.
Publicado: (2020)